| Secondary |
| Drug Use For Unknown Indication |
20.4% |
| Product Used For Unknown Indication |
14.5% |
| Depression |
11.2% |
| Pain |
7.1% |
| Schizophrenia |
6.5% |
| Psychotic Disorder |
5.4% |
| Anxiety |
4.7% |
| Laxative Supportive Care |
4.1% |
| Mental Disorder |
4.0% |
| Headache |
3.6% |
| Sedative Therapy |
2.7% |
| Neck Pain |
2.1% |
| Insomnia |
1.9% |
| Migraine |
1.9% |
| Hypertension |
1.7% |
| Intentional Overdose |
1.7% |
| Sedation |
1.7% |
| Adverse Drug Reaction |
1.6% |
| Schizophrenia, Paranoid Type |
1.6% |
| Antipsychotic Drug Level Therapeutic |
1.5% |
|
| Tachycardia |
16.7% |
| Suicide Attempt |
13.5% |
| Sudden Death |
9.5% |
| Urinary Retention |
9.5% |
| Suicidal Ideation |
8.7% |
| Vomiting |
4.8% |
| Syncope |
4.0% |
| Weight Increased |
4.0% |
| Faeces Hard |
3.2% |
| Haemorrhage Foetal |
3.2% |
| Personality Change |
3.2% |
| Enuresis |
2.4% |
| Myopathy |
2.4% |
| Pregnancy |
2.4% |
| Rash Maculo-papular |
2.4% |
| Somnolence |
2.4% |
| Tremor |
2.4% |
| Ventricular Fibrillation |
2.4% |
| Atrial Septal Defect |
1.6% |
| Cardiac Arrest |
1.6% |
|
| Concomitant |
| Schizophrenia |
14.0% |
| Schizophrenia, Paranoid Type |
12.3% |
| Drug Use For Unknown Indication |
11.2% |
| Anxiety |
9.1% |
| Depression |
8.2% |
| Product Used For Unknown Indication |
6.7% |
| Psychotic Disorder |
6.0% |
| Pneumonia |
3.7% |
| Mental Disorder |
3.4% |
| Pain |
3.0% |
| Bipolar Disorder |
2.8% |
| Insomnia |
2.8% |
| Schizoaffective Disorder |
2.8% |
| Agitation |
2.2% |
| Hypertension |
2.2% |
| Restlessness |
2.2% |
| Attention Deficit/hyperactivity Disorder |
1.9% |
| Hiv Infection |
1.9% |
| Osteoporosis |
1.9% |
| Prophylaxis |
1.9% |
|
| Tachycardia |
17.9% |
| Weight Increased |
12.5% |
| Agranulocytosis |
10.7% |
| Suspiciousness |
5.4% |
| Hepatitis Toxic |
4.5% |
| Neutropenia |
4.5% |
| Urinary Tract Infection |
4.5% |
| Drug Interaction |
3.6% |
| Extrapyramidal Disorder |
3.6% |
| Metabolic Disorder |
3.6% |
| Restlessness |
3.6% |
| Stevens-johnson Syndrome |
3.6% |
| Vomiting |
3.6% |
| Completed Suicide |
2.7% |
| Enuresis |
2.7% |
| Epistaxis |
2.7% |
| Hypertension |
2.7% |
| Serotonin Syndrome |
2.7% |
| Somnolence |
2.7% |
| Toxicity To Various Agents |
2.7% |
|
| Interacting |
| Product Used For Unknown Indication |
46.8% |
| Drug Use For Unknown Indication |
26.6% |
| Delusional Disorder, Persecutory Type |
7.6% |
| Drug Withdrawal Syndrome |
3.8% |
| Extrapyramidal Disorder |
3.8% |
| Mania |
3.8% |
| Schizoaffective Disorder |
3.8% |
| Psychotic Disorder |
2.5% |
| Hiv Infection |
1.3% |
|
| Drug Interaction |
20.0% |
| Tongue Spasm |
20.0% |
| Death |
13.3% |
| Restlessness |
13.3% |
| Gamma-glutamyltransferase Increased |
6.7% |
| Mania |
6.7% |
| Panic Reaction |
6.7% |
| Urticaria |
6.7% |
| Weight Increased |
6.7% |
|
